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Pharmaceutical terpenoids belong to the most diverse class of natural products. They
have significant curative effects on a variety of diseases, such as cancer, cardiovascular
diseases, malaria and Alzheimer’s disease. Nowadays, elicitors, including biotic and
abiotic elicitors, are often used to activate the pathway of secondary metabolism
and enhance the production of target terpenoids. Based on Agrobacterium-mediated
genetic transformation, several plant metabolic engineering strategies hold great
promise to regulate the biosynthesis of pharmaceutical terpenoids. Overexpressing
terpenoids biosynthesis pathway genes in homologous and ectopic plants is an
effective strategy to enhance the yield of pharmaceutical terpenoids. Another strategy
is to suppress the expression of competitive metabolic pathways. In addition, global
regulation which includes regulating the relative transcription factors, endogenous
phytohormones and primary metabolism could also markedly increase their yield. All
these strategies offer great opportunities to enhance the supply of scarce terpenoids
drugs, reduce the price of expensive drugs and improve people’s standards of living.
Keywords: medicinal plants, metabolic regulation, elicitors, overexpression, suppression, transcription factors,
endogenous phytohormones, ectopic expression
INTRODUCTION
Terpenoids are the most diverse class of natural products and over 40,000 different terpenoids have
been described (Misawa, 2011). Many of them are isolated from medicinal plants, such as Ginkgo
biloba, Taxus chinensis, Artemisia annua, Salvia miltiorrhiza, and Panax ginseng. Terpenoids
from plants, such as artemisinin, taxol and ginkgolides, have good curative effects on a variety
of diseases. Artemisinin, a sesquiterpenoids lactone derived from A. annua, is currently the
best therapeutic against both drug-resistant and cerebral malaria-causing strains of Plasmodium
falciparum (Weathers et al., 2006). Paclitaxel (taxol), a diterpenoid produced by Taxus brevifolia
and other Taxus-species is an important anticancer agent (Lenka et al., 2012). Ginkgolides, a
structurally unique family of diterpenoids, are highly specific platelet-activating factor receptor
antagonists (Stromgaard and Nakanishi, 2004).
However, at present the commercialization of pharmaceutical terpenoids is limited due to
their low yield from natural sources (Misawa, 2011). Many medicinal plants grow slowly and are
susceptible to environmental conditions. Some medicinal plants are endangered and cannot be
harvested for isolation of pharmaceutical terpenoids. Furthermore, the contents of pharmaceutical
terpenoids usually show large fluctuations, which is not conducive to the extraction and quality
control of drugs. Great efforts have been made to enhance the production of pharmaceutical
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terpenoids. However, the total chemical synthesis of these
complicated compounds is costly. While most of pharmaceutical
terpenoids biosynthetic pathways have not been resolved, the
biosynthesis in microorganisms is very difficult. Consequently,
researchers have carried out a number of studies on plant
metabolic engineering of pharmaceutical terpenoids (Table 1).
This review covers the plant metabolic engineering strategies for
the production of pharmaceutical terpenoids from 2009 to July
2016.
THE BIOSYNTHETIC PATHWAYS OF
PHARMACEUTICAL TERPENOIDS IN
MEDICINAL PLANTS
Despite the complex structure, terpenoids are biosynthesized
from the basic isoprene units, i.e., isopentenyl diphosphate
(IDP) and dimethylallyl diphosphate (DMADP). In plants,
there are two independent pathways to produce IDP and
DMADP (Figure 1). One is the methylerythritol phosphate
(MEP) pathway, which is localized in the plastids and starts
with the biosynthesis of 1-deoxy-D-xylulose 5-phosphate (DXP)
from D-glyceraldehyde 3-phosphate (GAP) and pyruvate (PYR)
(Banerjee and Sharkey, 2014). The MEP pathway, which
comprises seven enzymatic steps, is mainly regulated by 1-
deoxy-D-xylulose-5-phosphate synthase (DXS) and 1-deoxy-D-
xylulose-5-phosphate reductoisomerase (DXR) (Weathers et al.,
2011). The other pathway is the classical mevalonic acid (MVA)
pathway comprised of six enzymatic steps, which are localized
to the cytosol, endoplasmic reticulum (ER) and peroxisomes
(Gutensohn et al., 2014). 3-Hydroxy-3-methylglutaryl-CoA
reductase (HMGR) localized to peroxisomes is considered as a
rate-limiting step (Opitz et al., 2014) (Figure 1). There is an
unidirectional proton symport system between the cytosol and
the plastid resulting in transport of C5-precursors between the
two compartments (Bick and Lange, 2003).
The intermediates IDP and DMADP are condensed to a series
of linear terpenoid intermediates by prenyl transferases, which
are the precursors of different terpenoids. The terpenoids are
sorted into classes depending on the number of isoprene units:
monoterpenoids (C10), sesquiterpenoids (C15), diterpenoids
(C20), triterpenoids (C30), and tetraterpenoids (C40), as shown in
TABLE 1 | Pharmaceutical terpenoids production by plant metabolic engineering strategies.
Classes Metabolites Medicinal plants Strategy
Monoterpenoids Linalool L. latifolia Overexpression (Mendoza-Poudereux et al., 2014)
Geraniol N. tabacum Overexpression (Ritala et al., 2014); Global regulation (Vasilev et al., 2014)
Loganic acid;
Secologanin
C. roseus Global regulation (Van Moerkercke et al., 2015, 2016)
Sesquiterpenoids Artemisinin A. annua Overexpression (Lu et al., 2013a); Suppression ( Zhang et al., 2009; Lv et al., 2016);
Global regulation ( Yu et al., 2012; Lu et al., 2013b, 2014; Zhang et al., 2013, 2015; Han
J.L. et al., 2014; Ji et al., 2014; Tan et al., 2015; Shen et al., 2016)
Dihydroartemisinic acid A. annua Global regulation (Lu et al., 2013b, 2014; Shen et al., 2016); Suppression (Lv et al., 2016)
Artemisinic acid A. annua Global regulation (Yu et al., 2012; Lu et al., 2014; Shen et al., 2016)
Valencene N. benthamiana Suppression (Cankar et al., 2015)
Bilobalide G. biloba Elicitors (Kang et al., 2009)
Farnesene;
Bergamotene
N. attenuata Overexpression (Schuman et al., 2014)
Diterpenoids Paclitaxel T. chinensis;
T. media
Elicitors (Li et al., 2009; Xu et al., 2011; Zhou and Zhong, 2011; Onrubia et al., 2013)
Taxanes T. cuspidata;
C. avellana;
T. chinensis;
T. media
Elicitors (Patil et al., 2014; Gallego et al., 2015); Global regulation (Dong et al., 2015);
Combined (Expósito et al., 2010)
Taxadiene N. benthamiana Overexpression ( Hasan et al., 2014)
Tanshinones S. miltiorrhiza
S. castanea
Overexpression (Kai et al., 2011); Global regulation (Gu et al., 2012 )
Ginkgolides G. biloba Elicitors (Kang et al., 2009)
Andrographolide A. paniculata Elicitors (Praveen et al., 2009; Gandi et al., 2012)
Triterpenoids Ginsenosides P. ginseng Elicitors (Huang and Zhong, 2013); Overexpression ( Shim et al., 2010; Han et al., 2013;
Kim et al., 2014)
Maytenin P. campestris Elicitors (Paz et al., 2013)
Platycoside P. gradiflorum Overexpression (Kim Y.K. et al., 2013)
Dammarenediol-II;
Protopanaxadiol
N. tabacum Overexpression (Han J.Y. et al., 2014; Chun et al., 2015)
Tetraterpenoids Carotenoids I. batatas;
S. lycopersicum
Suppression (Kim S.H. et al., 2013); Global regulation (Sun et al., 2012)
Lycopene S. lycopersicum Global regulation (Sun et al., 2012)
Frontiers in Plant Science | www.frontiersin.org 2 November 2016 | Volume 7 | Article 1647
fpls-07-01647 November 4, 2016 Time: 17:11 # 3
Lu et al. Pharmaceutical Terpenoids Metabolic Regulation Strategies
Figure 1 (Smanski et al., 2012; Sato, 2013). IDP and DMADP are
condensed to the C10-compound geranyl diphosphate (GDP) by
geranyl diphosphate synthase (GDS) in the plastid. In the cytosol,
farnesyl diphosphate synthase (FDS) converts two molecules of
IDP and one molecule of DMADP to the C15-compound farnesyl
diphosphate (FDP), which is the precursor of sesquiterpenoids.
Two molecules of FDP can be condensed to squalene (the
precursor of triterpenoids) by squalene synthase (SQS) localized
to the ER membrane through a short C-terminal membrane-
spanning sequence. For the biosynthesis of diterpenoids in
the plastid, geranylgeranyl diphosphate synthase (GGDS) can
build the precursor of diterpenoids, geranylgeranyl diphosphate
(GGDP), by condensing three molecules of IDP and one molecule
of DMADP. Finally, two molecules of GGDP can form the
precursor of phytoene (tetraterpenoid), in the plastid (Loto et al.,
2012).
Subsequently, different terpene synthases (TPSs) use the linear
prenyl compounds as substrate to start the biosynthesis of specific
terpenoids. In the biosynthesis of pharmaceutical terpenoids,
further modifications are catalyzed by various cytochrome
P450-dependent oxidoreductases (CYP450s), acyltransferases,
glucosyltransferases and dehydrogenases. Recently, more and
more key genes of pharmaceutical terpenoid biosynthetic
pathways have been cloned from different medicinal plants (Guo
et al., 2013; Miettinen et al., 2014; Yan et al., 2014; Moses
et al., 2015). Artemisinin, a sesquiterpenoids lactone, is a natural
antimalarial drug and its discovery was awarded the 2015 Nobel
Prize in Physiology or Medicine. After extensive investigations
during the last years, the artemisinin biosynthetic pathway is
almost completely resolved (Bouwmeester et al., 1999; Brown
and Sy, 2004; Teoh et al., 2006, 2009; Zhang et al., 2008).
All studies mentioned above provide the theoretical support
FIGURE 1 | Biosynthetic pathway of pharmaceutical terpenoids. MVA, mevalonic acid; MEP, methylerythritol phosphate; PYR, pyruvate; G3P,
glyceraldehyde-3-phosphate; IDP, isopentenyl diphosphate; DMADP, dimethylallyl diphosphate; FDP, farnesyl diphosphate; GDP, geranyl diphosphate; GGDP,
geranylgeranyl diphosphate; ER, endoplasmic reticulum; DXP, 1-deoxy-D-xylulose-5-phosphate; DXS, DXP synthase; MEP, 2-C-methyl-D-erythritol-4-phosphate;
DXR, DXP reductase; CDP-ME, 4-diphosphocytidyl-2-C-methyl-D-erythritol; CMS, CDP-ME synthase; CDP-MEP, CDP-ME 2-phosphate; CMK, CDP-ME kinase;
MEcPP, 2-C-methyl-D-erythritol-2,4-cyclodiphosphate; MCS, MEcPP synthase; HMBPP, 1-hydroxy-2-methyl-2-(E)-butenyl-4-diphosphate; HDS, HMBPP synthase;
HDR, HMBPP reductase; AACS, acetoacetyl-CoA synthase; HMGS, hydroxymethylglutaryl (HMG)-CoA synthase; HMGR, HMG-CoA reductase; MVK, mevalonate
kinase; PMK, phosphomevalonate kinase; PMD, mevalonate diphosphate decarboxylase; IDI, isopentenyl diphosphate isomerase; GDS, geranyl diphosphate
synthase; FDS, farnesyl diphosphate synthase; GGDS, geranylgeranyl diphosphate synthase; SQS, squalene synthase; CrtB, phytoene synthase.
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to plant metabolic engineering studies for the production of
pharmaceutical terpenoids.
PLANT METABOLIC ENGINEERING
STRATEGIES FOR PRODUCTION OF
PHARMACEUTICAL TERPENOIDS
Elicitors
Pharmaceutical terpenoids of medicinal plants are often natural
defense metabolites against pathogen attacks. Elicitors, including
biotic and abiotic elicitors, can be used to activate the pathway
of secondary metabolism and enhance the production of target
terpenoids (Figure 2).
Biotic Elicitors
Biotic elicitors are obtained from living organisms such as
bacteria, viruses and fungi. Plant hormones (salicylic acid,
jasmonates, abscisic acid etc.) are involved in the response to
elicitors and can be used as substitutes for biotic elicitors (Cusido
et al., 2014). Several biotic elicitors have significant functions
in promoting the production of pharmaceutical terpenoids.
Kang et al. (2009) reported that a native bacterial elicitor
effectively increased the secondary metabolite accumulations
in G. biloba cell suspension cultures. After 24 h treatment
with native Staphylococcus aureus, the bilobalide, ginkgolide
A and ginkgolide B levels were enhanced 2.6-, 1.5- and 2.1-
fold, respectively, compared to the untreated control. Praveen
et al. (2009) established an adventitious root culture system
from leaf segments of Andrographis paniculata on Murashige
and Skoog (MS) medium with α-naphthaleneacetic acid (NAA).
The content of andrographolide (diterpenoid) was 3.5-fold
higher compared to the natural cells in suspension culture.
Adventitious root cultures of Peritassa campestris (Celastraceae)
were established from seed cotyledons cultured in semisolid
Woody Plant Medium (WPM) supplemented with sucrose, PVP
and IBA. The highest content of maytenin (a quinone-methide
triterpenoid) in adventitious root culture was 972 µg/g DW
after cultivation for 7 days (Paz et al., 2013). It was 5.55-fold
higher than that found in the roots of seedlings grown in a
greenhouse. Biotic elicitors are also important tools to produce
the important anti-cancer drug paclitaxel. A 20-L bioreactor was
used for paclitaxel production by co-culturing Taxus chinensis
suspension cells and its endophytic fungi, Fusarium mairei.
Within co-culture of 15 days, 25.6 mg/L of paclitaxel was
produced. The productivity is 1.71 mg/L per day and 38-fold
higher than that by uncoupled culture (0.68 mg/L within 15 days)
(Li et al., 2009). During the cell culture process, different biotic
elicitors are used to enhance the production of paclitaxel. Several
labs focused their studies on selecting a more powerful elicitor
for inducing paclitaxel biosynthesis in suspension cell lines.
The results showed that coronatine, methyl jasmonate (MeJA),
salicylic acid (SA) and abscisic acid (ABA) are useful elicitors
that can affect the biosynthesis of paclitaxel and related taxanes
(Li et al., 2009; Xu et al., 2011; Zhou and Zhong, 2011; Onrubia
et al., 2013). Recently, some researchers reported that coronatine
and MeJA treatments may repress the growth of suspension
cells. One example is cell suspension cultures of Corylus avellana
producing taxanes. Treatments with MeJA or coronatine resulted
in a statistically significant reduction in suspension cells growth
FIGURE 2 | Plant metabolic engineering strategies to regulate pharmaceutical terpenoids.
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from 11.5 g DCW/L to 4.28 g DCW/L and 5.69 g DCW/L,
respectively, after 14 days, while the total taxane content was
increased 3- and 27-fold, respectively (Gallego et al., 2015). In
another study on the effects of MeJA on cell suspension culture
of Taxus cuspidata, the growth of MeJA treated cultures decreased
from 14 g DW/L to 8 g DW/L (Patil et al., 2014). Essentially no
taxanes were produced in the untreated cell cultures but after
MeJA-treatment the yield of paclitaxel was 2.5 mg/g DW of
cells. Consequently, despite affecting the growth of suspension
cells, MeJA or coronatine may be effectively used for increased
paclitaxel production in Taxus cell suspension cultures.
Abiotic Elicitors
Abiotic elicitors include inorganic compounds (copper sulfate,
silver nitrate, etc.) and metal ions (Cusido et al., 2014). There
are only a few reports on the use of abiotic elicitors for the
production of pharmaceutical terpenoids in cell suspension
cultures. Andrographolide, a diterpenoid lactones, exhibits
important pharmacological activities such as anticancer, anti-
HIV, and anti-inflammatory (Srivastava and Akhila, 2010). Gandi
et al. (2012) reported that abiotic elicitors (CdCl2, AgNO3,
CuCl2 and HgCl2) were used to enhance the andrographolide
content in suspension cultures of A. paniculata. Among all
those metal salts, the treatment with CdCl2 had the strongest
effect on andrographolide production, which could reach
6.3 mg/g DCW, whereas the control accumulated 1.5 mg/g
DCW.
The use of abiotic elicitors was an effective strategy
for increasing the production of triterpenoid ginsenosides
in suspension cultures of P. ginseng. Huang and Zhong
(2013) described that heavy metal salts, including NaVO3,
NH4VO3, NiSO4, VOSO4, CuSO4 and MnSO4, were used to
induce ginsenoside biosynthesis. Vanadate was demonstrated
to be the most efficient of all the treatments tested. After
4 days treatment with vanadate, the highest ginsenoside
(Rg1 + Re+ Rb1 + Rc+ Rd) content was 5.6 mg/g DW (day 14).
Further research showed that vanadate treatment induced the
endogenous JA biosynthesis and up-regulated the transcription
levels of SQS, squalene epoxidase (SE) and dammarenediol-II
synthase (DS) genes.
Homologous Overexpression of
Pharmaceutical Terpenoid Biosynthesis
Key Genes
Overexpression of Single Gene
As pharmaceutical terpenoid production is strictly controlled
by enzymes of the biosynthetic pathways, one way to increase
the productivity is to regulate the expression of such genes
(De Geyter et al., 2012). Ginsenosides, a group of triterpenoids,
which can be divided into protopanaxadiols (Rb1, Rb2, Rc and
Rd) and protopanaxatriols (Re, Rf, and Rg1), are the main
pharmacological active constituents of P. ginseng (Qi et al.,
2011). During recent years, several genes of the ginsenosides
biosynthetic pathway have been cloned and overexpessed in
P. ginseng. Overexpression of ginsenosides biosynthetic pathway
key gene PgSQS1, which can up-regulate the expression
of SE, β-amyrin synthase (β-AS) and cycloartenol synthase
(CAS), resulted in a twofold increase of phytosterols and
1.6- to 3-fold increase of total ginsenosides in transgenic
ginseng adventitious root cultures. However, the growth rate of
transgenic ginseng roots is slower than that of non-transgenic
adventitious roots (Shim et al., 2010). Han et al. (2013)
described that overexpression of ginsenoside biosynthesis key
gene CYP716A52v2 greatly enhanced the content of oleanane-
type ginsenoside (ginsenoside Ro) in P. ginseng plants, while
the levels of other dammarene-type ginsenosides were similar
to the control lines. By A. tumefaciens-mediated transformation,
the PgHMGR gene was overexpressed and enhanced the
accumulation of ginsenosides 1.5- to 2-fold in transgenic ginseng
adventitious root cultures (Kim et al., 2014).
Co-expression of Multiple Genes
Metabolic regulation of multiple key genes in biosynthetic
pathways can effectively increase the pharmaceutical terpenoids
content in medicinal plants. Tanshinones are abietane-
type norditerpenoid quinines in S. miltiorrhiza. They have
antibacterial, anti-inflammatory effects and broad antitumor
activities (Dong et al., 2011; Gao et al., 2014). The introduction
of the SmHMGR and/or SmGGDS gene, as well as SmDXS gene in
S. miltiorrhiza hairy root lines result in a significant enhancement
of tanshinone production (Kai et al., 2011). Co-expression of the
SmHMGR and SmGGDS genes resulted in the highest production
of tanshinone (about 2.7 mg/g DW), which was about 4.7-fold
higher than the control (0.475 mg/g DW). Overexpression
of artemisinin biosynthesis genes ADS (Amorpha-4,11-diene
synthase gene), CYP71AV1 (cytochrome P450-dependent
hydroxylase gene) and CPR (NADPH: cytochrome P450
oxidoreductase gene) promoted the accumulation of artemisinin
in A. annua. The artemisinin content could reach 15.1 mg/g dry
weight (DW), which was 2.4-fold higher than the control plants
(Lu et al., 2013a).
Ectopic Expression of Biosynthetic
Genes to Produce Pharmaceutical
Terpenoids
Some medicinal plants, which produce low yields of
pharmaceutical terpenoids in native plants, are hard to
genetically transform. Several researchers have used ectopic
expression of terpenoid synthases/cyclases (TPSs) to produce
pharmaceutical terpenoids in different plants. Geraniol is a
monoterpenoid alcohol, with important commercial value in
fragrance industries due to its pleasant rose-like odor, and
it can also be used as an anticancer drugs and antimicrobial
reagents (Unlu et al., 2010; Polo et al., 2011). A geraniol
synthase gene from Valeriana officinalis (VoGES) was engineered
to produce geraniol in tobacco hairy root cultures. GC–MS
analysis revealed that the free geraniol content in 20 hairy
root cultures was with an average of 13.7 µg/g DW and the
maximum was 31.3 µg/g DW. Metabolic analysis revealed that
there were six major glycoside forms of geraniol derivatives.
After deglycosylation, the total geraniol levels were up to
204 µg/g DW (Ritala et al., 2014). High content of linalool
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and low content of camphor are desired in Lavandula latifolia
(spike lavender) oils for the perfume and cosmetic industries
(Kaloustian et al., 2000). The linalool synthase (LIS) gene
from Clarkia breweri, encoding the linalool synthase was
overexpressed in L. latifolia plants. The linalool content was
increased significantly in the transgenic L. latifolia young leaves,
where the linalool content increased up to 10-fold (Mendoza-
Poudereux et al., 2014). Maize (Zea mays) terpene synthase10
(ZmTPS10), which produces the sesquiterpenes (E)-β-farnesene
and (E)-α-bergamotene, was ectopically overexpressed in
Nicotiana attenuata. Transgenic N. attenuata plants contained
2- to 25-fold more (E)-α-bergamotene than the wild-type
plants. Jasmonate elicitors or herbivore treatment could further
induce an increased emission of (E)-β-farnesene and (E)-
α-bergamotene in the transgenic N. attenuata plants (Schuman
et al., 2014).
Taxadiene, which is the first committed product of paclitaxel
biosynthesis, is produced by taxadiene synthase (TS) from
GGDP. Hasan et al. (2014) constitutively overexpressed the
TbTS gene in N. benthamiana. Transformed N. benthamiana
line produced 11–27 µg/g DW taxadiene. The plants were
further treated with MeJA, and the accumulation of taxadiene
increased to 35 µg/g DW. Ectopic overexpression of other
terpenoid biosynthesis genes may also increase the productivity
of triterpenoids. By Agrobacterium rhizogenes-mediated ectopic
transformation, overexpression of Panax ginseng HMGR1
(PgHMGR1) resulted in 1.1- to 1.6-fold increase of phytosterols
and 1.5- to 2.5-fold higher platycoside yields in Platycodon
gradiflorum hairy root cultures (Kim Y.K. et al., 2013). Several
researchers overexpressed ginsenoside biosynthesis key gene
PgDS or PgDS plus PgCYP716A47 in transgenic tobacco plants.
Overexpression of PgDS gene resulted in more dammarenediol-
II accumulated in transgenic tobacco roots than stems, leaves and
flower buds. Dammarenediol-II production could reach 158µg/g
DW in the root of transgenic line. And its accumulation in the
cell suspension culture could reach 573 µg/g DW after 3 weeks
of culture (Han J.Y. et al., 2014). After co-overexpressing PgDS
and PgCYP716A47 (CYP450 gene of Ginsenosides biosynthesis
pathway) in tobacco, the concentration of protopanaxadiol
(PPD) was 2.3–5.7 µg/g DW in transgenic tobacco leaves. 2,4-
D treatment could increase the expression of HMGR and SE in
cell suspension culture. The production of PPD in a 250-ml shake
flask culture or in a 5-L airlift bioreactor culture was 167 and
981 µg/g DW, respectively (Chun et al., 2015).
Suppression of Competitive Pathways to
Increase the Production of
Pharmaceutical Terpenoids
Another strategy is to suppress the expression of competitive
metabolic pathways. The sterol pathway is a competitive pathway
of artemisinin biosynthesis in A. annua. Downregulation of
the expression of SQS, a key gene of sterol pathway, by
RNA interference (RNAi), resulted in a significant increase
of artemisinin content in transgenic plants, with the highest
values reaching 31.4 mg/g DW, which is about 3.14-fold higher
than the control plants (Zhang et al., 2009). Four competitive
branch pathway genes β-caryophyllene synthase gene (CPS),
β-farnesene synthase gene (BFS), germacrene A synthase gene
(GAS) and SQS were further down-regulated independently by
the antisense method in A. annua. The content of artemisinin and
dihydroartemisinic acid (DHAA) were increased significantly
in different transgenic lines. In anti-CPS transgenic plants, the
contents of artemisinin and DHAA were increased by 77 and
132%, respectively. In anti-BFS transgenic plants, the contents
of artemisinin and DHAA were increased by 77 and 54%,
respectively. In anti-GAS transgenic plants, the contents of
artemisinin and DHAA were enhanced by 103% and 130%,
respectively. In anti-SQS transgenic plants, the contents of
artemisinin and DHAA were enhanced by 71 and 223%,
respectively (Lv et al., 2016). Carotenoids (tetraterpenes), which
exert a wide range of functions in the plant kingdom, are required
for human health (Mo and Elson, 1999). To increase carotenoid
biosynthesis via the β-branch-specific pathway, the expression
of lycopene ε-cyclase (LCY-ε) gene, which is the first gene of
competitive branch pathway, was downregulated by RNAi (Kim
S.H. et al., 2013). It was shown that the β-carotene content was
approximately 21-fold higher in the sweetpotato transgenic calli
than in the control, whereas the lutein content was reduced to
levels undetectable in the transgenic calli. The (+)-valencene
is an aroma sesquiterpenoid. Silencing the endogenous 5-epi-
aristolochene synthase gene (EAS) and SQS, which are competing
for the FDP pool, by RNAi resulted in a 2.8-fold increased yield
of (+)-valencene in N. benthamiana plants (Cankar et al., 2015).
Regulating the Expression of
Transcription Factors
Transcription factors have important functions in controlling
the transcription of biosynthetic genes and they may constitute
important tools to regulate the production of secondary
metabolites in plants (Vom Endt et al., 2002) (Figure 2). Several
types of transcription factors have already showed to have global
regulation functions in pharmaceutical terpenoids.
AP2/ERF Transcription Factors
AP2/ERF transcription factors, which carry a conserved binding
domain of 57–66 amino acids, are involved in plant response
to biotic and abiotic stresses, as well as in the regulation
of metabolism in various plant species (Agarwal et al.,
2006). Recently, AP2/ERF transcription factors have received
attention in artemisinin metabolic engineering. Overexpression
of AaERF1 and AaERF2, which are able to bind to the
CRTDREHVCBF2 (CBF2) and RAV1AAT (RAA) motifs of
ADS and CYP71AV1 promoters, enhanced the contents of
artemisinin and artemisinic acid in transgenic A. annua plants
(Yu et al., 2012). Overexpression of a trichome-specific AP2/ERF
transcription factor AaORA resulted in a significant increase
in artemisinin and DHAA. The disease resistance to Botrytis
cinerea was also increased in these transgenic A. annua plants
(Lu et al., 2013b). Another AP2/ERF transcription factor,
TRICHOME AND ARTEMISININ REGULATOR 1 (TAR1),
which binds to the cis-acting elements of ADS and CYP71AV1
promoters, was cloned from A. annua. RNAi of TAR1 caused a
decreased accumulation of artemisinin and abnormal phenotype
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of glandular specific trichomes (GSTs) and T-shaped non-
glandular trichomes in transgenic A. annua plants, as well as
altered cuticular wax load. On the other hand, overexpression
of TAR1 markedly increased the content of artemisinin in
transgenic A. annua lines (Tan et al., 2015).
WRKY Transcription Factors
Transcription factors of WRKY family, which can specifically
bind to the W-box (TTGACC/T) of promoters, are involved
in regulating defense responses and developmental and
physiological processes of plants, such as trichome initiation,
senescence and metabolism (Rushton et al., 2010). The
AaWRKY1 gene was cloned from a GST cDNA library of A.
annua (Ma et al., 2009). The trichome-specific overexpression of
AaWRKY1 effectively improved the transcription of CYP71AV1,
i.e., up to 33 times as compared to the wild-type plants. However,
the transcription levels of FDS, ADS and DBR2 (a double
bond reductase 2 in artemisinin biosynthesis pathway) did not
change significantly in these transgenic A. annua. However, the
significantly up-regulated CYP71AV1 increased the production
of artemisinin by about 1.8-fold in transgenic plants (Han J.L.
et al., 2014).
Basic Helix–Loop–Helix (bHLH) Transcription Factors
The basic helix–loop–helix (bHLH) transcription factors are
found in all eukaryotic organisms and are involved in a myriad
of regulatory processes. Iridoids and (seco)iridoids (including
loganic acid and secologanin) are monoterpenoids. Many of
these compounds are bioactive themselves, with among others
anticancer, antimicrobial and anti-inflammatory activities (Dinda
et al., 2007a,b; Viljoen et al., 2012). The jasmonate-regulated
bHLH transcription factor (bHLH iridoid synthesis 1, BIS1)
was cloned from Catharanthus roseus. BIS1 could transactivate
the expression of the genes involved in the conversion of
the terpenoid precursor GDP to iridoids loganic acid and
secologanin. Overexpression of BIS1 was effective to boost
production of high-value iridoids and monoterpenoid indole
alkaloids (MIAs) in C. roseus suspension cell cultures (Van
Moerkercke et al., 2015). A jasmonate (JA)-responsive bHLH
TF BIS2 could transactivate promoters of iridoid biosynthesis
genes and can homodimerise or form heterodimers with
BIS1. Stable overexpression of BIS2 in C. roseus suspension
cells and transient ectopic expression of BIS2 in C. roseus
petal limbs resulted in increased transcript accumulation of
methylerythritol-4-phosphate and iridoid pathway genes (Van
Moerkercke et al., 2016). A bHLH transcription factor from
A. annua, AabHLH1, was cloned from a GST cDNA library.
The AabHLH1 protein binds to the E-box cis-elements in both
ADS and CYP71AV1 promoters, and possessed transactivation
activity in yeast. Transient expression of AabHLH1 in A. annua
leaves increased transcript levels of ADS, CYP71AV1 and HMGR,
which are all involved in artemisinin biosynthesis (Ji et al., 2014).
Recently, AaMYC2, which was rapidly induced by JA and could
bind to the G-box like motifs in the promoters of CYP71AV1
and DBR2, was cloned. Compared with the WT, overexpression
of AaMYC2 significantly increased the content of artemisinin
and DHAA in transgenic A. annua. Meanwhile, the content of
artemisinic acid, which was the competitive pathway product,
was significantly reduced in AaMYC2 overexpressing lines (Shen
et al., 2016).
Basic Leucine Zipper (bZIP) Transcription Factors
A basic leucine zipper family transcription factor (AabZIP1) was
cloned from A. annua. Overexpression of AabZIP1 upregulates
the expression of ADS and CYP71AV1 and promotes the
biosynthesis of artemisinin in transgenic A. annua plants.
Compared to wild-type lines, the artemisinin content increased
0.7- to 1.5-fold (Zhang et al., 2015). Hence, all these transcription
factors could be plant metabolic engineering tools for sustainable
production of high-value pharmaceutical terpenoids in medicinal
plants.
Regulating the Levels of Endogenous
Phytohormones Involved in Terpenoid
Biosynthesis
Terpenoid biosynthesis is often induced by herbivore feeding
or pathogen attack (Vranová et al., 2012). The transcriptional
response is controlled by a complex signaling cascade in which
jasmonate hormones (JAs) play a crucial role (Moses et al., 2013;
Ahmad et al., 2016). Hence, the production of pharmaceutical
terpenoids may be regulated through the jasmonate biosynthetic
pathway in plants. Overexpression of allene oxide cyclase gene
from S. miltiorrhiza (SmAOC), the key enzyme of the jasmonate
biosynthetic pathway, significantly enhanced the expression
levels of genes of the diterpenoids biosynthetic pathway and
increased the yields of tanshinone IIA, rosmarinic acid and
lithospermic acid B in S. miltiorrhiza hairy root cultures (Gu
et al., 2012). Jasmonates also play crucial roles in the regulation
of artemisinin biosynthesis. The allene oxide cyclase gene from
A. annua (AaAOC) was cloned and overexpressed in A. annua
plants and the content of endogenous JA was increased 2- to
4.7-fold compared to the control. The increased endogenous
JA promoted the expression levels of FDS, CYP71AV1 and
DBR2, which resulted in a significant increased production
of artemisinin, DHAA and artemisinic acid (Lu et al., 2014).
However, high concentrations of JA in plants may inhibit plant
growth, which limit the use of this method.
The phytohormone abscisic acid (ABA), which plays an
important role in plant development and environmental
stress response, may also participate in the regulation of the
pharmaceutical terpenoid biosynthesis. The SlNCED1 gene,
which encodes the enzyme 9-cis-epoxycarotenoid dioxygenase
(NCED) of the ABA biosynthetic pathway, was suppressed in
tomato by a fruit-specific E8 promoter driven RNAi construct.
Compared to the control, SlNCED1 transcript levels were
down-regulated to 20–50% in the transgenic tomato, which
partially blocked the carbon flow to free ABA and ABA
metabolite accumulation. The decrease in endogenous ABA
resulted in an increase in ethylene formation due to an increased
transcription of ethylene biosynthesis pathway genes during
ripening. The blocked carbon flow also influenced the carotenoid
pathway of the RNAi lines resulting in increased lycopene
and β-carotene accumulation. Therefore, tomato fruit of RNAi
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FIGURE 3 | The production of pharmaceutical terpenoids by plant metabolic engineering. (A) The cultivation of transgenic plants (B) Hariy root culture
(C) Plant cell-suspension culture (D) Adventitious root culture.
lines displayed deep red coloration compared to the control
fruit during ripening (Sun et al., 2012). ABA treatment could
also increase the production of artemisinin (Lu et al., 2011).
The full-length cDNA of ABA receptor AaPYL9 was cloned
and characterized from A. annua. Overexpression of AaPYL9
increases not only drought tolerance, but also artemisinin
content after ABA treatment, with significant enhancement of
the expression of artemisinin biosynthesis genes (Zhang et al.,
2013).
Regulating Related Primary Metabolism
Improving the productivity of pharmaceutical terpenoids can
also be achieved by regulating the relevant primary metabolism
of medical plants. Carbohydrates are important products
of primary metabolism. A large-scale statistical experiment
showed that carbohydrates played a major role in determining
the geraniol yield in transgenic tobacco cell suspension
cultures. Among sucrose, glucose and D-mannitol, the use
of sucrose led to the highest geraniol yield and biomass
accumulated in the cell cultures. Light, which can promote
the synthesis of carbohydrates by photosynthesis, had also a
potent effect on geraniol biosynthesis (Vasilev et al., 2014).
Overexpressing the neutral/alkaline invertase gene (NINV),
a key gene of sucrose hydrolysis, can significantly enhance
the expression level of taxadiene synthase gene (TAS) in
T. chinensis cells. The mean contents of seven individual taxanes
including 10-deatetylbaccatin III, baccatin III, 10-deacetyl taxol,
cephalomanine, 7-epi-10-deatetyl taxol, taxol, and 7-epi taxol
were 2.1, 3.3, 2.2, 3.7, 3.5, 1.9 and 1.8 times higher than the
controls, respectively. Thus, regulating the TcNINV-mediated
sucrose metabolism can promote the biosynthesis of taxanes
(Dong et al., 2015).
CONCLUSIONS AND PERSPECTIVES
Nowadays, more and more studies combined these metabolic
regulation strategies to produce target terpenoids. For
example, Taxus × media hairy root cultures were obtained
by overexpressing TXS gene from Taxus baccata but showed
poor growth capacity. To resolve this problem, transgenic hairy
roots were dedifferentiated to callus by hormonal treatment and
cell suspension lines were obtained. After MeJA treatment, the
taxane production reached the highest in the TXS cell line, which
was 2.65-fold higher than the untransformed control (Expósito
et al., 2010).
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Plant metabolic engineering strategies hold great promise
to upregulate the content of pharmaceutical terpenoids in
medicinal plants. After a series of metabolic regulations in
medicinal plants, the production of pharmaceutical terpenoids
can be greatly improved. Compared with the control, transgenic
plants, which integrate aimed DNA into the host genome
by the tumor inducing (Ti) plasmid, had significantly higher
pharmaceutical terpenoids. And those transgenic plants can
greatly improved the production of pharmaceutical terpenoids
(Figure 3A). Compared to cultivation of plants, plant cell
cultures, including hariy root cultures, cell-suspension cultures
and adventitious root cultures, have some advantages to
produce pharmaceutical terpenoids (Figures 3B–D). The most
important advantage is that the target terpenoids can be
harvested under controlled conditions (Bioreactor or Flask)
and with strict quality control. The growth cycles are much
faster than cultivation of the plant, and can be measured
in weeks rather than years (Rao and Ravishankar, 2002).
However, in some cases plant cell cultures do not produce
the target compounds, which limit the applicability of this
approach.
Many of these pharmaceutical terpenoids are complicated
compounds, and the biosynthetic pathways are not resolved. The
focus of plant metabolic engineering to produce pharmaceutical
terpenoids has shifted to reveal different TPSs, CYP450s,
glucosyltransferases and dehydrogenases involved in the
biosynthesis pathways of pharmaceutical terpenoids and to
explore overexpression of transcription factor involved in the
regulation of terpenoid biosynthesis. With the continuous
development of plant metabolic engineering, more and more
high value pharmaceutical terpenoids will be upregulated in the
future. We believe that all those strategies will enhance the supply
of scarce drugs, reduce the price of expensive drugs and improve
people’s standards of living.
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